Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles. (2011)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jncimonographs/lgr027

PubMed Identifier: 22043045

Publication URI: http://europepmc.org/abstract/MED/22043045

Type: Journal Article/Review

Volume: 2011

Parent Publication: Journal of the National Cancer Institute. Monographs

Issue: 43

ISSN: 1052-6773